MedPath

LUMAKRAS

LUMAKRAS

Approved
DIN Number

02520095

Drug Class

Human

Market Date

Oct 22, 2021

Company
HC

Amgen Canada Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02520095
AIG Number0163153001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L01XX73 SOTORASIB
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification10:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

SOTORASIBActive
Strength: 120 MG
Monograph: SOTORASIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.